Article
Biochemistry, Vol. 49, No. 43, 2010 9279
0
Inactivation of ribonucleotide reductase by (E)-2 -fluoromethylene-
0
41. Huang, F., Haydock, S. F., Spiteller, D., Mironenko, T., Li, T. L.,
O’Hagan, D., Leadlay, P. F., and Spencer, J. B. (2006) The gene
cluster for fluorometabolite biosynthesis in Streptomyces cattleya: A
thioesterase confers resistance to fluoroacetyl-coenzyme A. Chem.
Biol. 13, 475–484.
42. Dias, M. V., Huang, F., Chirgadze, D. Y., Tosin, M., Spiteller, D.,
Dry, E. F., Leadlay, P. F., Spencer, J. B., and Blundell, T. L. (2010)
Structural basis for the activity and substrate specificity of fluoroa-
cetyl-CoA thioesterase FlK. J. Biol. Chem. 285, 22495–22504.
43. Rouillard, J. M., Lee, W., Truan, G., Gao, X., Zhou, X., and Gulari,
E. (2004) Gene2Oligo: Oligonucleotide design for in vitro gene
synthesis. Nucleic Acids Res. 32, W176–180.
0
2 -deoxycytidine-5 -diphosphate: A paradigm for nucleotide mechanism-
based inhibitors. Biochemistry 35, 8381–8391.
4. Pourquier, P., Gioffre, C., Kohlhagen, G., Urasaki, Y., Goldwasser,
F., Hertel, L. W., Yu, S., Pon, R. T., Gmeiner, W. H., and Pommier,
Y. (2002) Gemcitabine (2 ,2 -difluoro-2 -deoxycytidine), an antimetabolite
that poisons topoisomerase I. Clin. Cancer Res. 8, 2499–2504.
5. Parker, W. B., and Cheng, Y. C. (1990) Metabolism and mechanism
of action of 5-fluorouracil. Pharmacol. Ther. 48, 381–395.
6. Longley, D. B., Harkin, D. P., and Johnston, P. G. (2003)
5-Fluorouracil: Mechanisms of action and clinical strategies. Nat.
Rev. Cancer 3, 330–338.
1
0
0
0
1
1
1
1
7. Chenoweth, M. B. (1949) Monofluoroacetic acid and related com-
pounds. J. Pharmacol. Exp. Ther. 97, 383–423.
8. Rowinsky, E. K., Cazenave, L. A., and Donehower, R. C. (1990)
Taxol: A novel investigational antimicrotubule agent. J. Natl. Cancer
Inst. 82, 1247–1259.
44. Tropea, J. E., Cherry, S., and Waugh, D. S. (2009) Expression and
purification of soluble His(6)-tagged TEV protease. Methods Mol.
Biol. 498, 297–307.
45. Kabsch, W. (1993) Automatic processing of rotation diffraction data
from crystals of initially unknown symmetry and cell constants.
J. Appl. Crystallogr. 212, 916–924.
46. McCoy, A. J., Grosse-Kunstsleve, R. W., Adams, P. D., Winn, M. D.,
Storoni, L. C., and Read, R. J. (2007) Phaser crystallographic soft-
ware. J. Appl. Crystallogr. 40, 658–674.
47. Adams, P. D., Grosse-Kunstsleve, R. W., Hung, L. W., Ioerger, T. R.,
McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter,
N. K., and Terwilliger, T. C. (2002) PHENIX: Building new software
for automated crystallographic structure determination. Acta Crys-
tallogr. D58, 1948–1954.
1
9. Buffa, P., and Peters, R. A. (1950) The in vivo formation of citrate
induced by fluoroacetate and its signficance. J. Physiol. 110, 488–500.
0. Buffa, P., Peters, R. A., and Wakelin, R. W. (1951) Biochemistry of
fluoroacetate poisoning. Isolation of an active tricarboxylic acid
fraction from poisoned kidney homogenates. Biochem. J. 48, 467–477.
1. Morrison, J. F., and Peters, R. A. (1954) Biochemistry of fluoro-
acetate poisoning: The effect of fluorocitrate on purified aconitase.
Biochem. J. 58, 473–479.
2
2
22. Clarke, D. D. (1991) Fluoroacetate and fluorocitrate: Mechanism of
action. Neurochem. Res. 16, 1055–1058.
48. Perrakis, A., Morris, R., and Lamzin, V. S. (1999) Automated protein
model building combined with iterative structure refinement. Nat.
Struct. Biol. 6, 458–463.
49. Emsley, P., and Cowtan, K. (2004) Coot: Model-building tools for
molecular graphics. Acta Crystallogr. D60, 2126–2132.
2
3. Brandt, M., Evans, S., Mendes-Morao, J., and Chappell, B. (1973)
Fluorocitrate inhibition of aconitate hydratase and the tricarboxylate
carrier of rat liver mitochondria. Biochem. J. 134, 217–224.
4. Villafranca, J. J., and Platus, E. (1973) Fluorocitrate inhibition of
aconitase. Reversibility of the inactivation. Biochem. Biophys. Res.
Commun. 55, 1197–1207.
2
50. Thoden, J. B., Zhuang, Z., Dunaway-Mariano, D., and Holden,
H. M. (2003) The structure of 4-hydroxybenzoyl-CoA thioesterase
from Arthrobacter sp. strain SU. J. Biol. Chem. 278, 43709–43716.
51. Song, F., Zhuang, Z., Finci, L., Dunaway-Mariano, D., Kniewel, R.,
Buglino, J. A., Solorzano, V., Wu, J., and Lima, C. D. (2006)
Structure, function, and mechanism of the phenylacetate pathway
hot dog-fold thioesterase PaaI. J. Biol. Chem. 281, 11028–11038.
52. Cheng, Z., Song, F., Shan, X., Wei, Z., Wang, Y., Dunaway-Mariano,
D., and Gong, W. (2006) Crystal structure of human thioesterase super-
family member 2. Biochem. Biophys. Res. Commun. 349, 172–177.
53. Zhuang, Z., Song, F., Zhao, H., Li, L., Cao, J., Eisenstein, E., Herzberg,
O., and Dunaway-Mariano, D. (2008) Divergence of function in the
hot dog fold enzyme superfamily: The bacterial thioesterase YciA.
Biochemistry 47, 2789–2796.
2
5. Eanes, R. Z., and Kun, E. (1974) Inhibition of liver aconitase isozymes
by (-)-erythro-fluorocitrate. Mol. Pharmacol. 10, 130–139.
6. Kent, T. A., Emptage, M. H., Merkle, H., Kennedy, M. C., Beinert,
H., and Munck, E. (1985) Mossbauer studies of aconitase. Substrate
and inhibitor binding, reaction intermediates, and hyperfine inter-
actions of reduced 3Fe and 4Fe clusters. J. Biol. Chem. 260, 6871–
2
6
881.
2
7. Lauble, H., Kennedy, M. C., Emptage, M. H., Beinert, H., and Stout,
C. D. (1996) The reaction of fluorocitrate with aconitase and the
crystal structure of the enzyme-inhibitor complex. Proc. Natl. Acad.
Sci. U.S.A. 93, 13699–13703.
2
2
3
3
3
3
8. Marais, J. (1943) Isolation of the toxic principle “K cymonate” from
“
Gifblaar” Dichapetalum cymosum. J. Vet. Sci. Anim. Ind. 18, 203–206.
9. Vickery, B., and Vickery, M. (1972) Fluoride metabolism in Dicha-
petalum toxicarium. Phytochemistry 11, 1905–1909.
54. Cao, J., Xu, H., Zhao, H., Gong, W., and Dunaway-Mariano, D.
(2009) The mechanisms of human hotdog-fold thioesterase 2
(hTHEM2) substrate recognition and catalysis illuminated by a
structure and function based analysis. Biochemistry 48, 1293–1304.
55. Chen, D., Wu, R., Bryan, T. L., and Dunaway-Mariano, D. (2009)
In vitro kinetic analysis of substrate specificity in enterobactin biosyn-
thetic lower pathway enzymes provides insight into the biochemical
function of the hot dog-fold thioesterase EntH. Biochemistry 48, 511–513.
56. Kunishima, N., Asada, Y., Sugahara, M., Ishijima, J., Nodake, Y.,
Miyano, M., Kuramitsu, S., and Yokoyama, S. (2005) A novel
induced-fit reaction mechanism of asymmetric hot dog thioesterase
PAAI. J. Mol. Biol. 352, 212–228.
57. Song, F., Zhuang, Z., and Dunaway-Mariano, D. (2007) Structure-
activity analysis of base and enzyme-catalyzed 4-hydroxybenzoyl
coenzyme A hydrolysis. Bioorg. Chem. 35, 1–10.
58. Yokoyama, T., Choi, K. J., Bosch, A. M., and Yeo, H. J. (2009)
Structure and function of a Campylobacter jejuni thioesterase Cj0915,
a hexameric hot dog fold enzyme. Biochim. Biophys. Acta 1794,
1073–1081.
59. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J.
(1990) Basic local alignment search tool. J. Mol. Biol. 215, 403–410.
60. Edgar, R. C. (2004) MUSCLE: Multiple sequence alignment with
high accuracy and high throughput. Nucleic Acids Res. 32, 1792–1797.
61. Howard, J., Hoy, V., O’Hagan, D., and Smith, G. (1996) How good is
fluorine as a hydrogen bond acceptor? Tetrahedron 52, 12613–12622.
62. Dunitz, J., and Taylor, R. (1997) Organic fluorine hardly ever accepts
hydrogen bonds. Chem.;Eur. J. 3, 89–98.
63. Zhou, P., Zou, J., Tian, F., and Shang, Z. (2009) Fluorine bonding;
How does it work in protein ligand interactions? J. Chem. Inf. Model.
49, 2344–2355.
64. Shimazu, M., Vetcher, L., Galazzo, J. L., Licari, P., and Santi, D. V.
(2004) A sensitive and robust method for quantification of intracel-
lular short-chain coenzyme A esters. Anal. Biochem. 328, 51–59.
0. Hall, R. (1972) The distribution of organic fluorine in some toxic
tropical plants. New Phytol. 71, 855–871.
1. Twigg, L., and King, D. (1991) The impact of fluoroacetate-bearing
vegetation on native Australian fauna: A review. Oikos 61, 412–430.
2. Harper, D. B., and O’Hagan, D. (1994) The fluorinated natural
products. Nat. Prod. Rep. 11, 123–133.
3. Sanada, M., Miyano, T., Iwadare, S., Williamson, J. M., Arison,
B. H., Smith, J. L., Douglas, A. W., Liesch, J. M., and Inamine, E.
(
1986) Biosynthesis of fluorothreonine and fluoroacetic acid by the
thienamycin producer, Streptomyces cattleya. J. Antibiot. (Tokyo) 39,
59–265.
2
3
4. Dong, C., Huang, F., Deng, H., Schaffrath, C., Spencer, J. B.,
O’Hagan, D., and Naismith, J. H. (2004) Crystal structure and
mechanism of a bacterial fluorinating enzyme. Nature 427, 561–565.
5. Benveniste, R., and Davies, J. (1973) Aminoglycoside antibiotic-
inactivating enzymes in actinomycetes similar to those present in
clinical isolates of antibiotic-resistant bacteria. Proc. Natl. Acad. Sci.
U.S.A. 70, 2276–2280.
3
3
6. Cundliffe, E. (1978) Mechanism of resistance to thiostrepton in the
producing-organism Streptomyces azureus. Nature 272, 792–795.
7. Fierro, J. F., Hardisson, C., and Salas, J. A. (1988) Involvement of cell
impermeability in resistance to macrolides in some producer strepto-
mycetes. J. Antibiot. (Tokyo) 41, 142–144.
8. Thiara, A. S., and Cundliffe, E. (1988) Cloning and characterization
of a DNA gyrase B gene from Streptomyces sphaeroides that confers
resistance to novobiocin. EMBO J. 7, 2255–2259.
3
3
3
4
9. Cundliffe, E. (1989) How antibiotic-producing organisms avoid
suicide. Annu. Rev. Microbiol. 43, 207–233.
0. Mendez, C., and Salas, J. A. (1998) ABC transporters in antibiotic-
producing actinomycetes. FEMS Microbiol. Lett. 158, 1–8.